Oxurion/Investors/News/Oxurion NV to Present Preclinical Evaluation of Plasma Ka…

Oxurion NV to Present Preclinical Evaluation of Plasma Kallikrein Inhibition for DME at 2019 EURETINA Winter Meeting

28 Feb 2019General